Synlait Backs a2 Milk’s U.S. Infant Formula Recall, Sees No Financial Hit

Synlait Milk Ltd. ( (NZ:SML) ) has issued an announcement.

Synlait Milk Limited is collaborating with The a2 Milk Company on a voluntary recall of three batches of a2 Platinum USA label infant formula after tests detected cereulide, a toxin, under new New Zealand Ministry for Primary Industries directives. The affected product, which Synlait says was manufactured in line with all standards and had already been discontinued, is being removed as the company emphasizes its strict food safety stance and rapid reporting, while indicating the recall is not expected to affect its financial results.

Synlait is publicly backing the recall decision and directing concerned consumers to contact The a2 Milk Company, underscoring its commitment to quality control in a sensitive infant formula segment. The episode highlights heightened regulatory scrutiny and testing requirements in dairy nutritionals but suggests limited immediate financial impact for Synlait, with the focus instead on maintaining trust in its manufacturing and safety systems.

The most recent analyst rating on (NZ:SML) stock is a Hold with a N$0.72 price target. To see the full list of analyst forecasts on Synlait Milk Ltd. stock, see the NZ:SML Stock Forecast page.

More about Synlait Milk Ltd.

Synlait Milk Limited is a New Zealand-based dairy processor that manufactures value-added milk products, including infant formula. Listed on the NZX and ASX, the company focuses on high-specification nutritionals for global markets, supplying branded partners such as The a2 Milk Company.

YTD Price Performance: -33.59%

Average Trading Volume: 118,126

Technical Sentiment Signal: Strong Sell

Current Market Cap: N$256.4M

For detailed information about SML stock, go to TipRanks’ Stock Analysis page.